2023 Q1 Form 10-K Financial Statement

#000168316823002039 Filed on March 31, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $2.342M $8.448M
YoY Change 40.16% 34.64%
Cost Of Revenue $1.102M $4.245M
YoY Change 32.75% 40.03%
Gross Profit $1.240M $4.203M
YoY Change 47.49% 29.61%
Gross Profit Margin 52.94% 49.75%
Selling, General & Admin $1.025M $4.335M
YoY Change 10.51% 1.04%
% of Gross Profit 82.66% 103.14%
Research & Development $271.6K $1.070M
YoY Change 7.26% -5.26%
% of Gross Profit 21.91% 25.47%
Depreciation & Amortization $12.70K $43.83K
YoY Change 33.26% 0.83%
% of Gross Profit 1.02% 1.04%
Operating Expenses $1.309M $5.449M
YoY Change 10.0% -0.26%
Operating Profit -$69.30K -$1.246M
YoY Change -80.17% -43.88%
Interest Expense -$1.600K -$23.54K
YoY Change -10.11% 11.72%
% of Operating Profit
Other Income/Expense, Net -$24.07K
YoY Change -101.33%
Pretax Income -$70.90K -$1.270M
YoY Change -79.81% 213.71%
Income Tax $7.680K $15.04K
% Of Pretax Income
Net Earnings -$78.58K -$1.285M
YoY Change -78.0% 211.35%
Net Earnings / Revenue -3.36% -15.21%
Basic Earnings Per Share $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 299.2M shares 299.2M shares 296.5M shares
Diluted Shares Outstanding 296.5M shares

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.244M $3.244M
YoY Change 37.38% 37.38%
Cash & Equivalents $3.244M $3.244M
Short-Term Investments
Other Short-Term Assets $702.5K $702.5K
YoY Change -4.43% -4.43%
Inventory $1.306M $1.306M
Prepaid Expenses $702.5K
Receivables $1.958M $2.053M
Other Receivables $0.00 $0.00
Total Short-Term Assets $7.305M $7.305M
YoY Change 40.53% 40.53%
LONG-TERM ASSETS
Property, Plant & Equipment $126.1K $569.0K
YoY Change 49.76% -13.09%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $447.5K $4.600K
YoY Change -22.59% -39.47%
Total Long-Term Assets $573.6K $573.6K
YoY Change -13.39% -13.39%
TOTAL ASSETS
Total Short-Term Assets $7.305M $7.305M
Total Long-Term Assets $573.6K $573.6K
Total Assets $7.879M $7.879M
YoY Change 34.44% 34.44%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.146M $1.146M
YoY Change -38.59% -38.59%
Accrued Expenses $702.6K $846.3K
YoY Change -2.25% -7.4%
Deferred Revenue $650.3K
YoY Change -18.81%
Short-Term Debt $0.00 $0.00
YoY Change -100.0% -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.662M $2.662M
YoY Change -33.26% -33.26%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $619.9K $619.9K
YoY Change -35.42% -35.42%
Total Long-Term Liabilities $619.9K $619.9K
YoY Change -35.42% -35.42%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.662M $2.662M
Total Long-Term Liabilities $619.9K $619.9K
Total Liabilities $3.282M $3.282M
YoY Change -33.68% -33.68%
SHAREHOLDERS EQUITY
Retained Earnings -$130.0M
YoY Change 1.0%
Common Stock $299.2K
YoY Change 119.51%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $4.597M $4.597M
YoY Change
Total Liabilities & Shareholders Equity $7.879M $7.879M
YoY Change 34.44% 34.44%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income -$78.58K -$1.285M
YoY Change -78.0% 211.35%
Depreciation, Depletion And Amortization $12.70K $43.83K
YoY Change 33.26% 0.83%
Cash From Operating Activities -$476.5K -$3.598M
YoY Change 22.55% 111.71%
INVESTING ACTIVITIES
Capital Expenditures $920.00 $87.55K
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $1.300K
YoY Change
Cash From Investing Activities -$920.00 -$86.25K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 $4.567M
YoY Change -100.0% 335.44%
NET CHANGE
Cash From Operating Activities -476.5K -$3.598M
Cash From Investing Activities -920.0 -$86.25K
Cash From Financing Activities 0.000 $4.567M
Net Change In Cash -477.4K $882.5K
YoY Change 89.43% -235.62%
FREE CASH FLOW
Cash From Operating Activities -$476.5K -$3.598M
Capital Expenditures $920.00 $87.55K
Free Cash Flow -$477.4K -$3.686M
YoY Change 116.86%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001094084
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-31972
CY2022 dei Entity Registrant Name
EntityRegistrantName
TELKONET, INC.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
UT
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-0627421
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
20800 Swenson Drive
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 175
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Waukesha
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
WI
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
53186
CY2022 dei City Area Code
CityAreaCode
(414)
CY2022 dei Local Phone Number
LocalPhoneNumber
302-2299
CY2022 dei Security12g Title
Security12gTitle
Common Stock, $0.001 par value
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
11968491 usd
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
299212282 shares
CY2022 dei Auditor Firm
AuditorFirmId
344
CY2022 dei Auditor Name
AuditorName
Wipfli LLP
CY2022 dei Auditor Location
AuditorLocation
Minneapolis, Minnesota
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3243594 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2361059 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1958103 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1010554 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
1306186 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
825559 usd
CY2022Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
94840 usd
CY2021Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
266014 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
702500 usd
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
735092 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
7305223 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
5198278 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
126096 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
84201 usd
CY2022Q4 us-gaap Deposits Assets
DepositsAssets
4595 usd
CY2021Q4 us-gaap Deposits Assets
DepositsAssets
7595 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
442903 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
570512 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
447498 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
578107 usd
CY2022Q4 us-gaap Assets
Assets
7878817 usd
CY2021Q4 us-gaap Assets
Assets
5860586 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1145658 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1865535 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
702583 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
718721 usd
CY2022Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
0 usd
CY2021Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
403089 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
650340 usd
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
800965 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
157334 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
195176 usd
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
6297 usd
CY2021Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
5431 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2662212 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3988917 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
350694 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
459668 usd
CY2022Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
49213 usd
CY2021Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
140265 usd
CY2022Q4 us-gaap Accrued Royalties Current And Noncurrent
AccruedRoyaltiesCurrentAndNoncurrent
220000 usd
CY2021Q4 us-gaap Accrued Royalties Current And Noncurrent
AccruedRoyaltiesCurrentAndNoncurrent
360000 usd
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
619907 usd
CY2021Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
959933 usd
CY2022Q4 us-gaap Liabilities
Liabilities
3282119 usd
CY2021Q4 us-gaap Liabilities
Liabilities
4948850 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
475000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
475000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
299212282 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
299212282 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
136311335 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
136311335 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
299212 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
136311 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
132578075 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
127740976 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-129953413 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-128668176 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
4596698 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
911736 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7878817 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5860586 usd
CY2022 us-gaap Revenues
Revenues
8448019 usd
CY2021 us-gaap Revenues
Revenues
6274399 usd
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
4245149 usd
CY2021 us-gaap Cost Of Revenue
CostOfRevenue
3031660 usd
CY2022 us-gaap Gross Profit
GrossProfit
4202870 usd
CY2021 us-gaap Gross Profit
GrossProfit
3242739 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1070473 usd
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1129957 usd
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4334698 usd
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4289920 usd
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
43832 usd
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
43471 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
5449003 usd
CY2021 us-gaap Operating Expenses
OperatingExpenses
5463348 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-1246133 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-2220609 usd
CY2022 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 usd
CY2021 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
1836780 usd
CY2022 us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
-526 usd
CY2021 us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
0 usd
CY2022 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-23542 usd
CY2021 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-21067 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-24068 usd
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1815713 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1270201 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-404896 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15036 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7889 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-1285237 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-412785 usd
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
296497266 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
136311335 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
296497266 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
136311335 shares
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
1317259 usd
CY2021 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
7262 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-412785 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
911736 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
911736 usd
CY2022 TKOI Stock And Warrants Issued In Vda Transaction
StockAndWarrantsIssuedInVdaTransaction
5000000 usd
CY2022 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
29801 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-1285237 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
4596698 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-1285237 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-412785 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
7262 usd
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
43832 usd
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
43471 usd
CY2022 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
-526 usd
CY2021 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
-0 usd
CY2022 us-gaap Other Noncash Expense
OtherNoncashExpense
127609 usd
CY2021 us-gaap Other Noncash Expense
OtherNoncashExpense
229548 usd
CY2022 us-gaap Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
-0 usd
CY2021 us-gaap Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
1836780 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
947549 usd
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
145380 usd
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
480627 usd
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-562703 usd
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-32592 usd
CY2021 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
592359 usd
CY2022 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
3000 usd
CY2021 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-595 usd
CY2022 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-719877 usd
CY2021 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
822528 usd
CY2022 us-gaap Increase Decrease In Royalties Payable
IncreaseDecreaseInRoyaltiesPayable
-140000 usd
CY2021 us-gaap Increase Decrease In Royalties Payable
IncreaseDecreaseInRoyaltiesPayable
-140000 usd
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-16138 usd
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
166063 usd
CY2022 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-241677 usd
CY2021 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-111137 usd
CY2022 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-171174 usd
CY2021 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
161025 usd
CY2022 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-146816 usd
CY2021 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-242305 usd
CY2022 us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
866 usd
CY2021 us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
5431 usd
CY2022 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-0 usd
CY2021 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-105745 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3598322 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1699615 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
87553 usd
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
-0 usd
CY2022 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1300 usd
CY2021 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-86253 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2022 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 usd
CY2021 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
913063 usd
CY2022 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
5000000 usd
CY2021 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
0 usd
CY2022 us-gaap Payments For Repurchase Of Other Equity
PaymentsForRepurchaseOfOtherEquity
29801 usd
CY2021 us-gaap Payments For Repurchase Of Other Equity
PaymentsForRepurchaseOfOtherEquity
-0 usd
CY2022 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
4434152 usd
CY2021 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
6764968 usd
CY2022 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
4837241 usd
CY2021 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
6629168 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4567110 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1048863 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
882535 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-650752 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2361059 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3011811 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3243594 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2361059 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
23542 usd
CY2021 us-gaap Interest Paid Net
InterestPaidNet
22885 usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-104456 usd
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_842_eus-gaap--ConcentrationRiskCreditRisk_ztqFyUIXqoH" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration: underline"><span id="xdx_866_zbCqOLkumHRf">Concentrations of Credit Risk</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments and related items, which potentially subject the Company to concentrations of credit risk, consist primarily of cash, cash equivalents and trade receivables. The Company places its cash and temporary cash investments with credit quality institutions. At times, such investments may be in excess of the FDIC insurance limit. The Company has never experienced any losses related to these balances. With respect to trade receivables, the Company performs ongoing credit evaluations of its customers’ financial conditions and limits the amount of credit extended when deemed necessary. The Company provides credit to its customers primarily in the United States in the normal course of business. The Company routinely assesses the financial strength of its customers and, as a consequence, believes its trade receivables credit risk exposure is limited.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2021Q4 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
5563 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1958103 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1010554 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
32058 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
5563 usd
CY2022Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
388000 usd
CY2021Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
443000 usd
CY2022 TKOI Property Plant And Equipment Estimated Useful Lives1
PropertyPlantAndEquipmentEstimatedUsefulLives1
2 to 10 years.
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
108704218 shares
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3349793 shares
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-1285237 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-412785 usd
CY2022 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
94850 usd
CY2021 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
94850 usd
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1380087 usd
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-507635 usd
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
296497266 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
136311335 shares
CY2022 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2021 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
296497266 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
136311335 shares
CY2022 us-gaap Guarantees Indemnifications And Warranties Policies
GuaranteesIndemnificationsAndWarrantiesPolicies
<p id="xdx_842_eus-gaap--GuaranteesIndemnificationsAndWarrantiesPolicies_zLLTCM8qoo01" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration: underline"><span id="xdx_86E_z4arwdGgrAZi">Guarantees and Product Warranties</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company records a liability for potential warranty claims in cost of sales at the time of sale. The amount of the liability is based on the trend in the historical ratio of claims to sales, the historical length of time between the sale and resulting warranty claim, new product introductions and other factors. The products sold are generally covered by a warranty for a period of one year. In the event the Company determines that its current or future product repair and replacement costs exceed its estimates, an adjustment to these reserves would be charged to earnings in the period such determination is made. For the years ended December 31, 2022 and 2021, the Company experienced returns of approximately <span id="xdx_900_ecustom--GuaranteesAndProductWarrantyReturnPercentage1_c20220101__20221231" title="Guarantees and product warranty return percentage"><span id="xdx_902_ecustom--GuaranteesAndProductWarrantyReturnPercentage1_c20210101__20211231" title="Guarantees and product warranty return percentage">1% to 3%</span></span> of materials included in cost of sales, respectively. As of December 31, 2022 and 2021, the Company recorded warranty liabilities in the amount of $<span id="xdx_906_eus-gaap--ProductWarrantyAccrual_iI_c20221231_zEuQdkJz2Gi1" title="Warranty liabilities">13,663</span> and $<span id="xdx_90D_eus-gaap--ProductWarrantyAccrual_iI_c20211231_zNIZIpEVaRoe" title="Warranty liabilities">46,650</span>, respectively, using this experience factor range.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Product warranties for the years ended December 31 are as follows:  </p> <table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--ScheduleOfAllowanceForDoubtfulAccountsTableTextBlock_z4IDe0tBPf2c" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Details-Product warranties)"> <tr style="vertical-align: bottom"> <td style="text-align: left"><span id="xdx_8B6_zSTUUeTI1aN7" style="display: none">Schedule of allowance for doubtful accounts</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: left">Beginning balance</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--ProductWarrantyAccrual_iS_pp0p0_c20220101__20221231_zSRDMPKHoEl9" style="width: 14%; text-align: right" title="Beginning balance">46,650</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--ProductWarrantyAccrual_iS_pp0p0_c20210101__20211231_zLWFNBgx6Sq5" style="width: 14%; text-align: right" title="Beginning balance">45,328</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Warranty claims incurred</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ProductWarrantyAccrualWarrantiesIssued_iN_pp0p0_di_c20220101__20221231_zr2LVWHqHna6" style="text-align: right" title="Warranty claims incurred">(14,659</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ProductWarrantyAccrualWarrantiesIssued_iN_pp0p0_di_c20210101__20211231_z3YlRZCfGUm5" style="text-align: right" title="Warranty claims incurred">(16,075</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Provision charged (credited) to expense</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--ProductWarrantyAccrualPeriodIncreaseDecrease_pp0p0_c20220101__20221231_z0nzoqAkNXdi" style="border-bottom: Black 1pt solid; text-align: right" title="Provision charged (credited) to expense">(18,328</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--ProductWarrantyAccrualPeriodIncreaseDecrease_pp0p0_c20210101__20211231_zbbXnpqjOYo8" style="border-bottom: Black 1pt solid; text-align: right" title="Provision charged (credited) to expense">17,397</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Ending balance</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--ProductWarrantyAccrual_iE_pp0p0_c20220101__20221231_zXqCwvdMauf6" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance">13,663</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--ProductWarrantyAccrual_iE_pp0p0_c20210101__20211231_z3icV0UgBAXk" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance">46,650</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A1_z1ODSUWj5Cm6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_842_eus-gaap--UseOfEstimates_zyZCKVI51JBk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span style="text-decoration: underline"><span id="xdx_86B_zTiZKNQZ3yB1">Use of Estimates</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with United States of America (U.S.) generally accepted accounting principles (“GAAP”) requires management to make certain estimates, judgments and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Estimates are used when accounting for items and matters such as revenue recognition and allowances for uncollectible accounts receivable, inventory obsolescence, depreciation and amortization, long-lived assets, taxes and related valuation allowance, income tax provisions, stock-based compensation, and contingencies. The Company believes that the estimates, judgments and assumptions are reasonable, based on information available at the time they are made. Actual results may differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2022 TKOI Guarantees And Product Warranty Return Percentage1
GuaranteesAndProductWarrantyReturnPercentage1
1% to 3%
CY2021 TKOI Guarantees And Product Warranty Return Percentage1
GuaranteesAndProductWarrantyReturnPercentage1
1% to 3%
CY2022Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
13663 usd
CY2021Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
46650 usd
CY2022Q4 us-gaap Investments And Cash
InvestmentsAndCash
2000000 usd
CY2022 TKOI Debt Instrument Decrease Forgiveness Including Interest
DebtInstrumentDecreaseForgivenessIncludingInterest
1836780 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
7262 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
702583 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
718721 usd
CY2021Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
46650 usd
CY2020Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
45328 usd
CY2022 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
14659 usd
CY2021 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
16075 usd
CY2022 us-gaap Product Warranty Accrual Period Increase Decrease
ProductWarrantyAccrualPeriodIncreaseDecrease
-18328 usd
CY2021 us-gaap Product Warranty Accrual Period Increase Decrease
ProductWarrantyAccrualPeriodIncreaseDecrease
17397 usd
CY2022Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
13663 usd
CY2021Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
46650 usd
CY2022 us-gaap Advertising Expense
AdvertisingExpense
3502 usd
CY2021 us-gaap Advertising Expense
AdvertisingExpense
10104 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1070473 usd
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1129957 usd
CY2022 us-gaap Revenues
Revenues
8448019 usd
CY2021 us-gaap Revenues
Revenues
6274399 usd
CY2022Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
400000 usd
CY2022Q4 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
1 pure
CY2021Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
1200000 usd
CY2022Q4 us-gaap Contract With Customer Asset Gross
ContractWithCustomerAssetGross
94840 usd
CY2021Q4 us-gaap Contract With Customer Asset Gross
ContractWithCustomerAssetGross
266014 usd
CY2021Q1 TKOI Variance In Contract Assets
VarianceInContractAssets
-104989 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
650340 usd
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
941230 usd
CY2021Q1 TKOI Variance In Contract Liabilities
VarianceInContractLiabilities
-1052367 usd
CY2022Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
1990161 usd
CY2021Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
1016117 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
32058 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
587453 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
507864 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
461357 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
423663 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
126096 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
84201 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
43832 usd
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
43471 usd
CY2022Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
252193 usd
CY2021Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
242131 usd
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
143706 usd
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
136584 usd
CY2022Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
778 usd
CY2021Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
16634 usd
CY2022Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
13663 usd
CY2021Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
46650 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
292243 usd
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
276722 usd
CY2009Q4 us-gaap Payments For Repurchase Of Warrants
PaymentsForRepurchaseOfWarrants
1628800 usd
CY2009Q4 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
0.33
CY2009Q4 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
13774 shares
CY2009Q4 us-gaap Shares Issued
SharesIssued
1075000 shares
CY2010Q3 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
5134626 shares
CY2010Q3 us-gaap Preferred Stock Convertible Shares Issuable
PreferredStockConvertibleSharesIssuable
38461 shares
CY2010Q3 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.13
CY2022 us-gaap Payments For Repurchase Of Warrants
PaymentsForRepurchaseOfWarrants
5211542 usd
CY2022 us-gaap Stock Issued During Period Shares Conversion Of Units
StockIssuedDuringPeriodSharesConversionOfUnits
38461 shares
CY2011Q2 us-gaap Preferred Stock Dividends Shares
PreferredStockDividendsShares
486 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
475000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
475000000 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
299212282 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
299212282 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
136311335 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
136311335 shares
CY2022 TKOI Warrants Exercised Shares
WarrantsExercisedShares
0 shares
CY2021 TKOI Warrants Exercised Shares
WarrantsExercisedShares
0 shares
CY2022 us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
0 shares
CY2021 us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
0 shares
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-266742 usd
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
0 usd
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
5053 usd
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
0 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
7262 usd
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-85028 usd
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
39875 usd
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-7398 usd
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
944 usd
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
-385135 usd
CY2022 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
-29705 usd
CY2021 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
26739 usd
CY2022 us-gaap Deferred Tax Expense From Stock Options Exercised
DeferredTaxExpenseFromStockOptionsExercised
0 usd
CY2021 us-gaap Deferred Tax Expense From Stock Options Exercised
DeferredTaxExpenseFromStockOptionsExercised
42782 usd
CY2022 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
3370 usd
CY2021 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-393 usd
CY2022 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
-252258 usd
CY2021 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
-408433 usd
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
267293 usd
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
416322 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15036 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7889 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
22499045 usd
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
22078280 usd
CY2022Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
0 usd
CY2021Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
17728 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
0 usd
CY2021Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
0 usd
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
502733 usd
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
638477 usd
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
23001778 usd
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
22734485 usd
CY2022Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
-0 usd
CY2021Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
-0 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
-0 usd
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
-0 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
23001778 usd
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
22734485 usd
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 usd
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 usd
CY2022Q4 us-gaap Operating Loss Carryforwards Valuation Allowance
OperatingLossCarryforwardsValuationAllowance
23000000 usd
CY2021Q4 us-gaap Operating Loss Carryforwards Valuation Allowance
OperatingLossCarryforwardsValuationAllowance
22730000 usd
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
175959 usd
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
229548 usd
CY2022 us-gaap Variable Lease Cost
VariableLeaseCost
135109 usd
CY2021 us-gaap Variable Lease Cost
VariableLeaseCost
122356 usd
CY2022 us-gaap Lease Cost
LeaseCost
311068 usd
CY2021 us-gaap Lease Cost
LeaseCost
351904 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
157334 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
195176 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
350694 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
459668 usd
CY2022 us-gaap Operating Lease Payments Use
OperatingLeasePaymentsUse
311068 usd
CY2021 us-gaap Operating Lease Payments Use
OperatingLeasePaymentsUse
242305 usd
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y2M12D
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y1M6D
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.085 pure
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.085 pure
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
193170 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
172424 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
158510 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
53184 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
0 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
0 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
577288 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
69260 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
508028 usd
CY2022 us-gaap Operating Lease Expense
OperatingLeaseExpense
311068 usd
CY2021 us-gaap Operating Lease Expense
OperatingLeaseExpense
351904 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
196724 usd
CY2022Q4 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
56724 usd
CY2022Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
140000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
220000 usd
CY2021Q4 us-gaap Sales And Excise Tax Payable Current And Noncurrent
SalesAndExciseTaxPayableCurrentAndNoncurrent
16634 usd
CY2020Q4 us-gaap Sales And Excise Tax Payable Current And Noncurrent
SalesAndExciseTaxPayableCurrentAndNoncurrent
31396 usd
CY2022 TKOI Sales Tax Collected
SalesTaxCollected
162710 usd
CY2021 TKOI Sales Tax Collected
SalesTaxCollected
85589 usd
CY2022 TKOI Provisions Reversals Of Sales Tax
ProvisionsReversalsOfSalesTax
-10610 usd
CY2021 TKOI Provisions Reversals Of Sales Tax
ProvisionsReversalsOfSalesTax
-7685 usd
CY2022 us-gaap Excise And Sales Taxes
ExciseAndSalesTaxes
167956 usd
CY2021 us-gaap Excise And Sales Taxes
ExciseAndSalesTaxes
92666 usd
CY2022Q4 us-gaap Sales And Excise Tax Payable Current And Noncurrent
SalesAndExciseTaxPayableCurrentAndNoncurrent
778 usd
CY2021Q4 us-gaap Sales And Excise Tax Payable Current And Noncurrent
SalesAndExciseTaxPayableCurrentAndNoncurrent
16634 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Maximum Employee Subscription Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate
0.04 pure
CY2022 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
0 usd
CY2021 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
0 usd

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001683168-23-002039-index-headers.html Edgar Link pending
0001683168-23-002039-index.html Edgar Link pending
0001683168-23-002039.txt Edgar Link pending
0001683168-23-002039-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
telkonet_ex1901.htm Edgar Link pending
telkonet_ex2301.htm Edgar Link pending
telkonet_ex3101.htm Edgar Link pending
telkonet_ex3102.htm Edgar Link pending
telkonet_ex3201.htm Edgar Link pending
telkonet_ex3202.htm Edgar Link pending
telkonet_i10k-123122.htm Edgar Link pending
tkoi-20221231.xsd Edgar Link pending
tkoi-20221231_lab.xml Edgar Link unprocessable
tkoi-20221231_pre.xml Edgar Link unprocessable
tkoi-20221231_def.xml Edgar Link unprocessable
tkoi-20221231_cal.xml Edgar Link unprocessable
telkonet_i10k-123122_htm.xml Edgar Link completed